Product NDC: | 0093-3147 |
Proprietary Name: | Cephalexin |
Non Proprietary Name: | Cephalexin |
Active Ingredient(s): | 500 mg/1 & nbsp; Cephalexin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-3147 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062702 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900930 |
Package NDC: | 0093-3147-93 |
Package Description: | 100 BLISTER PACK in 1 BOX (0093-3147-93) > 1 CAPSULE in 1 BLISTER PACK (0093-3147-19) |
NDC Code | 0093-3147-93 |
Proprietary Name | Cephalexin |
Package Description | 100 BLISTER PACK in 1 BOX (0093-3147-93) > 1 CAPSULE in 1 BLISTER PACK (0093-3147-19) |
Product NDC | 0093-3147 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cephalexin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19900930 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CEPHALEXIN |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |